<VariationArchive VariationID="492857" VariationName="NM_000475.5(NR0B1):c.1168+1_1168+20del" VariationType="Deletion" Accession="VCV000492857" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-28" DateCreated="2018-02-19" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="485817" VariationID="492857">
      <GeneList>
        <Gene Symbol="NR0B1" FullName="nuclear receptor subfamily 0 group B member 1" GeneID="190" HGNC_ID="HGNC:7960" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp21.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="30304206" stop="30309390" display_start="30304206" display_stop="30309390" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="30322538" stop="30327494" display_start="30322538" display_stop="30327494" Strand="-" />
          </Location>
          <OMIM>300473</OMIM>
          <Haploinsufficiency last_evaluated="2020-05-05" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NR0B1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-05-05" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NR0B1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000475.5(NR0B1):c.1168+1_1168+20del</Name>
      <CanonicalSPDI>NC_000023.11:30308175:CCTAAGGCCAGTACCCTTACCC:CC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp21.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="30308176" stop="30308195" display_start="30308176" display_stop="30308195" variantLength="20" positionVCF="30308175" referenceAlleleVCF="GCCTAAGGCCAGTACCCTTAC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="30326293" stop="30326312" display_start="30326293" display_stop="30326312" variantLength="20" positionVCF="30326292" referenceAlleleVCF="GCCTAAGGCCAGTACCCTTAC" alternateAlleleVCF="G" />
      </Location>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_858" sequenceAccession="LRG_858">
            <Expression>LRG_858:g.6184_6203del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_858t1" sequenceAccession="LRG_858t1">
            <Expression>LRG_858t1:c.1168+1_1168+20del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.30326295_30326314del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.30326295_30326314del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.30308178_30308197del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.30308178_30308197del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009814.1" sequenceAccession="NG_009814" sequenceVersion="1" change="g.6184_6203del">
            <Expression>NG_009814.1:g.6184_6203del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000475.5" sequenceAccession="NM_000475" sequenceVersion="5" change="c.1168+1_1168+20del" MANESelect="true">
            <Expression>NM_000475.5:c.1168+1_1168+20del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA658684286" DB="ClinGen" />
        <XRef Type="rs" ID="1555972943" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000475.5(NR0B1):c.1168+1_1168+20del AND Congenital adrenal hypoplasia, X-linked" Accession="RCV000582454" Version="1">
        <ClassifiedConditionList TraitSetID="3046">
          <ClassifiedCondition DB="MedGen" ID="C0342482">Congenital adrenal hypoplasia, X-linked</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-10-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000475.5(NR0B1):c.1168+1_1168+20del AND multiple conditions" Accession="RCV002530827" Version="2">
        <ClassifiedConditionList TraitSetID="10091">
          <ClassifiedCondition DB="MedGen" ID="C1848296">46,XY sex reversal 2</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0342482">Congenital adrenal hypoplasia, X-linked</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-04-06" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-04-06" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2018-02-19" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17576681</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7609262</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8855822</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9536098</ID>
        </Citation>
        <DescriptionHistory Dated="2023-02-02">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="10091" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="87" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Congenital adrenal hypoplasia, X-linked</ElementValue>
                <XRef ID="Congenital+adrenal+hypoplasia%2C+X-linked/7542" DB="Genetic Alliance" />
                <XRef ID="237764004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ADRENAL HYPOPLASIA, CONGENITAL, WITH HYPOGONADOTROPIC HYPOGONADISM</ElementValue>
                <XRef Type="MIM" ID="300200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Adrenal hypoplasia, congenital</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Isolated X-Linked Adrenal Hypoplasia Congenita</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked AHC</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">X-AHC</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">AHC</ElementValue>
                <XRef Type="MIM" ID="300200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">AHCH</ElementValue>
                <XRef Type="MIM" ID="300200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">NR0B1-related adrenal hypoplasia congenita includes both X-linked adrenal hypoplasia congenita (X-linked AHC) and Xp21 deletion (previously called complex glycerol kinase deficiency). X-linked AHC is characterized by primary adrenal insufficiency and/or hypogonadotropic hypogonadism (HH). Adrenal insufficiency is acute infantile onset (average age 3 weeks) in approximately 60% of affected males and childhood onset (ages 1-9 years) in approximately 40%. HH typically manifests in a male with adrenal insufficiency as delayed puberty (i.e., onset age &gt;14 years) and less commonly as arrested puberty at about Tanner Stage 3. Rarely, X-linked AHC manifests initially in early adulthood as delayed-onset adrenal insufficiency, partial HH, and/or infertility. Heterozygous females very occasionally have manifestations of adrenal insufficiency or hypogonadotropic hypogonadism. Xp21 deletion includes deletion of NR0B1 (causing X-linked AHC) and GK (causing glycerol kinase deficiency), and in some cases deletion of DMD (causing Duchenne muscular dystrophy). Developmental delay has been reported in males with Xp21 deletion when the deletion extends proximally to include DMD or when larger deletions extend distally to include IL1RAPL1 and DMD.</Attribute>
                <XRef ID="NBK1431" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="555" />
                <XRef ID="555" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000520059" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000576178" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301604</ID>
                <ID Source="BookShelf">NBK1431</ID>
              </Citation>
              <XRef ID="95702" DB="Orphanet" />
              <XRef ID="C0342482" DB="MedGen" />
              <XRef ID="MONDO:0010264" DB="MONDO" />
              <XRef Type="MIM" ID="300200" DB="OMIM" />
            </Trait>
            <Trait ID="1986" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">NR0B1-Related 46,XY CGD</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">NR0B1-related 46,XY complete gonadal dysgenesis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dosage-sensitive sex reversal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">46,XY SEX REVERSAL, DAX1-RELATED</ElementValue>
                <XRef Type="MIM" ID="300018" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">46XY sex reversal 2, dosage-sensitive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">46,XY sex reversal 2</ElementValue>
                <XRef ID="MONDO:0010226" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SRXY2</ElementValue>
                <XRef Type="MIM" ID="300018" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">DSS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9159" />
                <XRef ID="9159" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="LWPES/ESPE, 2006">
                <ID Source="PubMed">18947601</ID>
              </Citation>
              <XRef ID="C1848296" DB="MedGen" />
              <XRef ID="MONDO:0010226" DB="MONDO" />
              <XRef Type="MIM" ID="300018" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3046" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="87" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Congenital adrenal hypoplasia, X-linked</ElementValue>
                <XRef ID="Congenital+adrenal+hypoplasia%2C+X-linked/7542" DB="Genetic Alliance" />
                <XRef ID="237764004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ADRENAL HYPOPLASIA, CONGENITAL, WITH HYPOGONADOTROPIC HYPOGONADISM</ElementValue>
                <XRef Type="MIM" ID="300200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Adrenal hypoplasia, congenital</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Isolated X-Linked Adrenal Hypoplasia Congenita</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked AHC</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">X-AHC</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">AHC</ElementValue>
                <XRef Type="MIM" ID="300200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">AHCH</ElementValue>
                <XRef Type="MIM" ID="300200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">NR0B1-related adrenal hypoplasia congenita includes both X-linked adrenal hypoplasia congenita (X-linked AHC) and Xp21 deletion (previously called complex glycerol kinase deficiency). X-linked AHC is characterized by primary adrenal insufficiency and/or hypogonadotropic hypogonadism (HH). Adrenal insufficiency is acute infantile onset (average age 3 weeks) in approximately 60% of affected males and childhood onset (ages 1-9 years) in approximately 40%. HH typically manifests in a male with adrenal insufficiency as delayed puberty (i.e., onset age &gt;14 years) and less commonly as arrested puberty at about Tanner Stage 3. Rarely, X-linked AHC manifests initially in early adulthood as delayed-onset adrenal insufficiency, partial HH, and/or infertility. Heterozygous females very occasionally have manifestations of adrenal insufficiency or hypogonadotropic hypogonadism. Xp21 deletion includes deletion of NR0B1 (causing X-linked AHC) and GK (causing glycerol kinase deficiency), and in some cases deletion of DMD (causing Duchenne muscular dystrophy). Developmental delay has been reported in males with Xp21 deletion when the deletion extends proximally to include DMD or when larger deletions extend distally to include IL1RAPL1 and DMD.</Attribute>
                <XRef ID="NBK1431" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="555" />
                <XRef ID="555" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000520059" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000576178" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301604</ID>
                <ID Source="BookShelf">NBK1431</ID>
              </Citation>
              <XRef ID="95702" DB="Orphanet" />
              <XRef ID="C0342482" DB="MedGen" />
              <XRef ID="MONDO:0010264" DB="MONDO" />
              <XRef Type="MIM" ID="300200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1349584" SubmissionDate="2018-01-31" DateLastUpdated="2018-02-19" DateCreated="2018-02-19">
        <ClinVarSubmissionID localKey="NM_000475.4:c.1168+1_1168+20del|MedGen:C0342482" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV000692290" DateUpdated="2018-02-19" DateCreated="2018-02-19" Type="SCV" Version="1" SubmitterName="Clinical Molecular Genetics Laboratory, Johns Hopkins All Children's Hospital" OrgID="1027" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-10-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NR0B1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000475.4:c.1168+1_1168+20del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0342482" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB3203857</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6028758" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="16328651|MedGen:C0342482;C1848296" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003339842" DateUpdated="2024-02-28" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17576681</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9536098</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7609262</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8855822</ID>
          </Citation>
          <Comment>This variant is not present in population databases (gnomAD no frequency). This sequence change affects a splice site in intron 1 of the NR0B1 gene. While this variant is not anticipated to result in nonsense mediated decay, it likely alters RNA splicing and results in a disrupted protein product. This variant has not been reported in the literature in individuals affected with NR0B1-related conditions. ClinVar contains an entry for this variant (Variation ID: 492857). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant disrupts the C-terminus of the NR0B1 protein. Other variant(s) that disrupt this region (p.Gln395*, p.Asp459Glyfs*3, p.Ser431Ilefs*6) have been observed in individuals with NR0B1-related conditions (PMID: 7609262, 8855822). This suggests that this may be a clinically significant region of the protein. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NR0B1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.30326293_30326312del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0342482" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1848296" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="6028758" TraitType="Disease" MappingType="XRef" MappingValue="C0342482" MappingRef="MedGen">
        <MedGen CUI="C0342482" Name="Congenital adrenal hypoplasia, X-linked" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1349584" TraitType="Disease" MappingType="XRef" MappingValue="C0342482" MappingRef="MedGen">
        <MedGen CUI="C0342482" Name="Congenital adrenal hypoplasia, X-linked" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6028758" TraitType="Disease" MappingType="XRef" MappingValue="C1848296" MappingRef="MedGen">
        <MedGen CUI="C1848296" Name="46,XY sex reversal 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

